Emerging Concepts and Novel Therapeutics to Overcome Treatment Resistance in Prostate Cancer

Dear Colleagues,

Recently, a number of novel therapeutic agents have been developed for the treatment of advanced prostate cancer, including second-generation androgen-deprivation therapy, radionuclide therapy, PARP inhibitors, stereotactic body radiotherapy, and more recently, immunotherapy. While these treatments lead to improvements in overall survival, they have limited curative efficacy. Progress in characterizing the molecular landscape of metastatic prostate cancer has allowed important insights into mechanisms of therapeutic resistance against, and tumor progression towards lethal disease. For instance, lineage plasticity and neuroendocrine dedifferentiation have emerged as important mechanisms of resistance to androgen-deprivation therapy in prostate cancer. There is a critical need to understand the underpinnings of acquired resistance and develop rationalized therapeutic approaches for the treatment of prostate cancer.

This Special Issue of the International Journal of Molecular Sciences welcomes both original research articles and review papers addressing the molecular mechanisms involved in therapeutic resistance, lineage plasticity, and phenotypic reprogramming, leading to prostate cancer recurrence and, ultimately, lethal disease. We are particularly interested in manuscripts addressing molecular markers of treatment failure in prostate cancer patients, new molecular tools to overcome therapeutic resistance, and the development of novel therapeutics efficiently targeting metastatic tumors in pre-clinical models.

Prof. Dr. Natasha Kyprianou
Dr. Fabrice Lucien-Matteoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.